Sherry Aulin
Net worth: - $ as of 2026-10-30
Net worth: - $ as of 2026-10-30
Ms. Sherry Aulin, CPA, is on the Board of Directors at Defence Therapeutics Inc. Ms. Aulin was previously employed as a Chief Financial Officer by Xenon Pharmaceuticals, Inc. and a Senior Manager by KPMG LLP (Canada).
She received her undergraduate degree from the University of British Columbia.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-28 | 0 ( -.--% ) | - $ | 2026-10-30 |
| Companies | Position | Start |
|---|---|---|
| DEFENCE THERAPEUTICS INC. | Director/Board Member | 2026-09-28 |
| Companies | Position | End |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Director of Finance/CFO | 2025-06-29 |
KPMG LLP (Canada)
KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Provides audit, tax and advisory services | Corporate Officer/Principal | 2010-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Xenon Pharmaceuticals, Inc.
Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG LLP (Canada)
KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Provides audit, tax and advisory services | Commercial Services |
Defence Therapeutics Inc
Defence Therapeutics Inc Pharmaceuticals: MajorHealth Technology Engages in the research and development of anti-body drug conjugates | Health Technology |
Select your edition
All financial news and data tailored to specific country editions